FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2761313 · Received September 26, 2012

Report

Report Number
2024168-2012-06085
Event Type
Injury
Date Received
September 26, 2012
Date of Event
September 1, 2012
Report Date
September 4, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). GUIDE WIRE: BMW; INFLATION: MEDTRONIC; GUIDE CATH: CORDIS; SHEATH: CORDIS. THERE WERE NO REPORTED PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECTS OF DISSECTION IS LISTED IN THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE AS A KNOWN ADVERSE EVENT. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MILDLY TORTUOUS, MILDLY CALCIFIED, 90% STENOSED MID LEFT ANTERIOR DESCENDING ARTERY. AFTER PRE-DILATATION WITH A 2.0 X 12 MM VOYAGER BALLOON CATHETER, A 2.5 X 28 MM XIENCE V STENT WAS IMPLANTED. THERE WAS A DISSECTION AT THE PROXIMAL EDGE OF THE IMPLANTED STENT, SO A SECOND 2.75 X 12 MM XIENCE V WAS DEPLOYED TO COVER THE DISSECTION. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN PROCEDURE AND NO ADVERSE PATIENT EFFECTS. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 2022141

Patients

Seq Age Sex Outcome Treatment
1 49 YR Required Intervention CONCOMITANT MEDICAL DEVICES